Skip Navigation

European Heart Journal 1996 17(12):1814-1820;
Copyright © 1996 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sweetnam, P. M.
Right arrow Articles by Elwood, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sweetnam, P. M.
Right arrow Articles by Elwood, P. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 The European Society of Cardiology

Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease

The Caerphilly and Speedwell Studies

P. M. Sweetnam, H. F. Thomas, J. W. G. Yarnell, A. D. Beswick, I. A. Baker and P. C. Elwood

MRC Epidemiology Unit, Llandough Hospital Penarth, U.K. and Avon Health Authority Bristol, U.K.

Received 1 April 1996; accepted 4 April 1996.

Correspondence: P. M. Sweetnam. MRC Epidemiology Unit. Llandough Hospital. Penarth. South Glamorgan. CF64 2XW.U.K.

Abstract

AIMS: To use the ten year follow-up of the Caerphilly and Speedwell studies to assess the contributions of fibrinogen and viscosity to the prediction of risk of ischaemic heart disease.

METHODS AND RESULTS: Caerphilly and Speedwell are prospective studies based on representative samples of middle-aged males. Ischaemic heart disease morbidity and mortality were defined using hospital notes, repeat electrocardiographs and death certificates. There were 603 incident events among the 4860 men. Age-adjusted relative odds of ischaemic heart disease increased to 3.3 and 3.4 in the 20% of men with the highest levels of fibrinogen and viscosity, respectively. After standardizing for the major cardiovascular risk factors, these relative odds were 2.2 (95% confidence interval 1.6 to 3.1) for fibrinogen and 2.3 (95% confidence interval 1.7 to 3.2) for viscosity. When fibrinogen and viscosity were entered jointly, both remained significant (P<0.0l) predictors. Incidence of ischaemic heart disease increased with increasing fibrinogen at every level of viscosity, and vice versa. Interactions with lipids were also examined. There was no support for the suggestion that risk is independent of cholesterol level when fibrinogen is low.

CONCLUSIONS: Fibrinogen and viscosity are powerful, long term and independent predictors of the risk of ischaemic heart disease.

Key Words: Fibrinogen • viscosity • ischaemic heart disease • prospective study • interactions • cholesterol


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
HeartHome page
K W Lee, A D Blann, K Jolly, G Y H Lip, and on behalf of the BRUM Investigators
Plasma haemostatic markers, endothelial function and ambulatory blood pressure changes with home versus hospital cardiac rehabilitation: the Birmingham Rehabilitation Uptake Maximisation Study
Heart, December 1, 2006; 92(12): 1732 - 1738.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Smith, C. Patterson, J. Yarnell, A. Rumley, Y. Ben-Shlomo, and G. Lowe
Which Hemostatic Markers Add to the Predictive Value of Conventional Risk Factors for Coronary Heart Disease and Ischemic Stroke?: The Caerphilly Study
Circulation, November 15, 2005; 112(20): 3080 - 3087.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Woodward, G. D.O. Lowe, D. J. Campbell, S. Colman, A. Rumley, J. Chalmers, B. C. Neal, A. Patel, A. J. Jenkins, B. E. Kemp, et al.
Associations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke
Stroke, October 1, 2005; 36(10): 2143 - 2147.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. Yarnell, E. McCrum, A. Rumley, C. Patterson, V. Salomaa, G. Lowe, A. Evans, and on behalf of the MONICA Optional Haemostasis Study
Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study{dagger}
Eur. Heart J., February 2, 2005; 26(4): 332 - 342.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J.W.G Yarnell, C.C Patterson, P.M Sweetnam, and G.D.O Lowe
Haemostatic/inflammatory markers predict 10-year risk of IHD at least as well as lipids: the Caerphilly collaborative studies
Eur. Heart J., June 2, 2004; 25(12): 1049 - 1056.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Kerlin, B. C. Cooley, B. H. Isermann, I. Hernandez, R. Sood, M. Zogg, S. B. Hendrickson, M. W. Mosesson, S. Lord, and H. Weiler
Cause-effect relation between hyperfibrinogenemia and vascular disease
Blood, March 1, 2004; 103(5): 1728 - 1734.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
K. W. Lee and G. Y. H. Lip
Effects of Lifestyle on Hemostasis, Fibrinolysis, and Platelet Reactivity: A Systematic Review
Arch Intern Med, October 27, 2003; 163(19): 2368 - 2392.
[Abstract] [Full Text] [PDF]


Home page
Occup. Environ. Med.Home page
W Babisch, H Ising, and J E J Gallacher
Health status as a potential effect modifier of the relation between noise annoyance and incidence of ischaemic heart disease
Occup. Environ. Med., October 1, 2003; 60(10): 739 - 745.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
S. Kamath and G.Y.H. Lip
Fibrinogen: biochemistry, epidemiology and determinants
QJM, October 1, 2003; 96(10): 711 - 729.
[Full Text] [PDF]


Home page
Eur Heart JHome page
F. Kittel, F. Leynen, M. Stam, M. Dramaix, P. de Smet, R. Mak, G. De Backer, and M. Kornitzer
Job conditions and fibrinogen in 14226 Belgian workers. The Belstress study
Eur. Heart J., December 1, 2002; 23(23): 1841 - 1848.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. G.C. Spencer, D. Gurney, A. D. Blann, D. G. Beevers, and G. Y.H. Lip
Von Willebrand Factor, Soluble P-Selectin, and Target Organ Damage in Hypertension: A Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
Hypertension, July 1, 2002; 40(1): 61 - 66.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
S. Sato, M. Nakamura, M. Iida, Y. Naito, A. Kitamura, T. Okamura, Y. Nakagawa, H. Imano, M. Kiyama, H. Iso, et al.
Plasma Fibrinogen and Coronary Heart Disease in Urban Japanese
Am. J. Epidemiol., September 1, 2000; 152(5): 420 - 423.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. Y. Gardner, J. R. Lehmann, and D. L. Costa
Oil Fly Ash-Induced Elevation of Plasma Fibrinogen Levels in Rats
Toxicol. Sci., July 1, 2000; 56(1): 175 - 180.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J Danesh, R Collins, R Peto, and G.D.O Lowe
Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease
Eur. Heart J., April 1, 2000; 21(7): 515 - 520.
[PDF]


Home page
Occup. Environ. Med.Home page
G J Prescott, R J Lee, G R Cohen, R A Elton, A J Lee, F G R Fowkes, and R M Agius
Investigation of factors which might indicate susceptibility to particulate air pollution
Occup. Environ. Med., January 1, 2000; 57(1): 53 - 57.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. W. G. Yarnell, P. M. Sweetnam, A. Rumley, and G. D. O. Lowe
Lifestyle and Hemostatic Risk Factors for Ischemic Heart Disease : The Caerphilly Study
Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 271 - 279.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
C.W. Mulholland, P.C. Elwood, A. Davis, D.I. Thurnham, O. Kennedy, J. Coulter, A. Fehily, and J.J. Strain
Antioxidant enzymes, inflammatory indices and lifestyle factors in older men: a cohort analysis
QJM, October 1, 1999; 92(10): 579 - 585.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Maresca, A. Di Blasio, R. Marchioli, and G. Di Minno
Measuring Plasma Fibrinogen to Predict Stroke and Myocardial Infarction : An Update
Arterioscler. Thromb. Vasc. Biol., June 1, 1999; 19(6): 1368 - 1377.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. S. Rosenson, C. C. Tangney, and L. J. Mosca
Hormone Replacement Therapy Improves Cardiovascular Risk by Lowering Plasma Viscosity in Postmenopausal Women
Arterioscler. Thromb. Vasc. Biol., December 1, 1998; 18(12): 1902 - 1905.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. S. Rosenson and C. C. Tangney
Antiatherothrombotic Properties of Statins: Implications for Cardiovascular Event Reduction
JAMA, May 27, 1998; 279(20): 1643 - 1650.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. Danesh, R. Collins, P. Appleby, and R. Peto
Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease: Meta-analyses of Prospective Studies
JAMA, May 13, 1998; 279(18): 1477 - 1482.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. Koenig, M. Sund, B. Filipiak, A. Doring, H. Lowel, and E. Ernst
Plasma Viscosity and the Risk of Coronary Heart Disease : Results From the MONICA-Augsburg Cohort Study, 1984 to 1992
Arterioscler. Thromb. Vasc. Biol., May 1, 1998; 18(5): 768 - 772.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. J. Lee, P. I. Mowbray, G. D.O. Lowe, A. Rumley, F. G. R. Fowkes, and P. L. Allan
Blood Viscosity and Elevated Carotid Intima-Media Thickness in Men and Women : The Edinburgh Artery Study
Circulation, April 21, 1998; 97(15): 1467 - 1473.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.